CLS announces oversubscribed rights issue and increased directed issue
Lund, Sweden - Clinical Laserthermia Systems AB's (publ) ("CLS" or "the Company") rights issue, consisting of B shares and warrants ("Units"), with subscription period 14 - 28 April 2021, is completed. The rights issue was oversubscribed and CLS will thus receive approximately SEK 47.7 million before deductions for issue costs. 5,908,683 Units, corresponding to approximately 87 percent of the issue, were subscribed for on the basis of preferential rights (incl. Subscription commitments). In addition, 1,433,723 units were subscribed for without the support of preferential rights,